Share this
Immunocore $312.1 Million Aggregate Financing
Cooley Advises CEPI on its Partnership with VBI Vaccines Inc., to Develop VBI’s Vaccine Candidates Against Covid-19 Variants
Immunocore – $297 Million IPO
Genesis MedTech Acquires Drug Device Asset From TriReme Medical
UNION Therapeutics Enters Licensing Option Agreement with TFF Pharmaceuticals
Bavarian Nordic Acquires Two Commercial Vaccines from GlaxoSmithKline for €796 Million
Mission Therapeutics Enters Collaboration Agreement with AbbVie
Cooley Advises F-star on Collaborative Agreement with Denali Therapeutics
Bristol Meyers Enters Agreement with Five Prime
Immunocore Limited Series A $320 Million Financing
Cooley Advises Immunocore on Largest European Private Life Sciences Financing on Record
King's College Collaboration and Licence Agreement with UCB
Meda: Rottapharm l Madaus Acquisition
Wellcome Trust Collaboration and Option Agreement with Jansen and University of Leuven
Karolinska Development Joint Venture with Rosetta Capital